COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis
JMIR Public Health and Surveillance · 2024
DOI: 10.2196/54769 ↗At a glance
Metaanalyse in JMIR Public Health and Surveillance, 2024. Written by Tahani Al Rahbeni and 18 co-authors. Institution: Molecular Toxicology and Genetics, Riyadh Elm University, Riyadh, Saudi Arabia. Major MEDLINE topics: COVID-19, COVID-19 Vaccines, Systematic Reviews as Topic, Vaccination Hesitancy. Cited 54 times so far (Crossref); 115 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
The unprecedented emergence of the COVID-19 pandemic necessitated the development and global distribution of vaccines, making the understanding of global vaccine acceptance and hesitancy crucial to overcoming barriers to vaccination and achieving widespread immunization.
Objective
This umbrella review synthesizes findings from systematic reviews and meta-analyses to provide insights into global perceptions on COVID-19 vaccine acceptance and hesitancy across diverse populations and regions.
Methods
We conducted a literature search across major databases to identify systematic reviews and meta-analysis that reported COVID-19 vaccine acceptance and hesitancy. The AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews) criteria were used to assess the methodological quality of included systematic reviews. Meta-analysis was performed using STATA 17 with a random effect model. The data synthesis is presented in a table format and via a narrative.
Results
Our inclusion criteria were met by 78 meta-analyses published between 2021 and 2023. Our analysis revealed a moderate vaccine acceptance rate of 63% (95% CI 0.60%-0.67%) in the general population, with significant heterogeneity (I2 = 97.59%). Higher acceptance rates were observed among health care workers and individuals with chronic diseases, at 64% (95% CI 0.57%-0.71%) and 69% (95% CI 0.61%-0.76%), respectively. However, lower acceptance was noted among pregnant women, at 48% (95% CI 0.42%-0.53%), and parents consenting for their children, at 61.29% (95% CI 0.56%-0.67%). The pooled vaccine hesitancy rate was 32% (95% CI 0.25%-0.39%) in the general population. The quality assessment revealed 19 high-quality, 38 moderate-quality, 15 low-quality, and 6 critically low-quality meta-analyses.
Conclusions
This review revealed the presence of vaccine hesitancy globally, emphasizing the necessity for population-specific, culturally sensitive interventions and clear, credible information dissemination to foster vaccine acceptance. The observed disparities accentuate the need for continuous research to understand evolving vaccine perceptions and to address the unique concerns and needs of diverse populations, thereby aiding in the formulation of effective and inclusive vaccination strategies. Trial Registration PROSPERO CRD42023468363; https://tinyurl.com/2p9kv9cr
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Molecular Toxicology and Genetics, Riyadh Elm University, Riyadh, Saudi Arabia.
- Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
- School of Management, The Apollo University, Chittoor, India.
- Faculty of Humanities and Health Sciences, Curtin University, Miri Sarawak, Malaysia.
- Division of Evidence Synthesis, Global Consortium of Public Health and Research, Datta Meghe Institute of Higher Education, Wardha, India.
- One Health Centre (COHERD), Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education, Wardha, India.
ORCID profiles: Tahani Al Rahbeni, Prakasini Satapathy, Ramaiah Itumalla, Roy Rillera Marzo, Khalid A L Mugheed, Mahalaqua Nazli Khatib, Shilpa Gaidhane, Quazi Syed Zahiruddin, Ali A Rabaan, Hayam A Alrasheed, Maha F Al-Subaie, Nawal A Al Kaabil, Mohammed Alissa, Amani Ahmed A L Ibrahim, Hussain Abdulkhaliq Alsaif, Israa Habeeb Naser, Sarvesh Rustagi, Neelima Kukreti, Arkadiusz Dziedzic
Cite
APA
Rahbeni, T. A., Satapathy, P., Itumalla, R., Marzo, R. R., Mugheed, K. A. L., Khatib, M. N., Gaidhane, S., Zahiruddin, Q. S., Rabaan, A. A., Alrasheed, H. A., Al-Subaie, M. F., Al Kaabil, N. A., Alissa, M., Ibrahim, A. A. A. L., Alsaif, H. A., Naser, I. H., Rustagi, S., Kukreti, N., & Dziedzic, A. (2024). COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis. JMIR Public Health and Surveillance. https://doi.org/10.2196/54769
Vancouver
Rahbeni TA, Satapathy P, Itumalla R, Marzo RR, Mugheed KAL, Khatib MN, et al. COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis. JMIR Public Health and Surveillance. 2024. doi:10.2196/54769
BibTeX
@article{Rahbeni2024,
author = {Rahbeni, Tahani Al and Satapathy, Prakasini and Itumalla, Ramaiah and Marzo, Roy Rillera and Mugheed, Khalid A L and Khatib, Mahalaqua Nazli and Gaidhane, Shilpa and Zahiruddin, Quazi Syed and Rabaan, Ali A and Alrasheed, Hayam A and Al-Subaie, Maha F and Al Kaabil, Nawal A and Alissa, Mohammed and Ibrahim, Amani Ahmed A L and Alsaif, Hussain Abdulkhaliq and Naser, Israa Habeeb and Rustagi, Sarvesh and Kukreti, Neelima and Dziedzic, Arkadiusz},
title = {COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis},
journal = {JMIR Public Health and Surveillance},
year = {2024},
doi = {10.2196/54769}
}
EUVIMED